Table:
begin	end	state
1	19	non-cytoplasmic
20	41	transmembrane
42	52	cytoplasmic
53	73	transmembrane
74	84	non-cytoplasmic
85	113	transmembrane
114	133	cytoplasmic
134	152	transmembrane
153	181	non-cytoplasmic
182	202	transmembrane
203	213	cytoplasmic
214	235	transmembrane
236	254	non-cytoplasmic
255	277	transmembrane
278	335	cytoplasmic
336	354	transmembrane
355	360	non-cytoplasmic
361	385	transmembrane
386	394	cytoplasmic

Input:
>WP_090442758.1 NCBI__GCF_900100495.1:WP_090442758.1
MQTTANTSRPRASVWTDPKVRAWLFQILAVIVVVALGWYLFDNTQTNLEKRGIISGFAFL
NNSAGFGIAQHLIDYSESDTYGRVFVIGLLNTLLVSVIGIVGATILGFILGVARLSPNWL
IGKLATVYIETFRNIPPLLQIFFWYFAVMLSLPGPRQSLEIGQAFFLNSRGLYMPAPSPT
EAFVTFVGALVVAIIGAVLVARWSKKRFEATGKLFPVSLGAVPLLLGLPGLAVLLTGNPL
QWSTPELTGFNFRGGWVMIPELIALTLALTIYTAAFIAENVRSGILAVSHGQTEAARSLG
LPAGKTLRLVIIPQALRVIIPPLTSQYLNLAKNSSLAAGIGYPDMVSLFAGTVLNQTGQA
IEVIAITMSVYLAISISISMLMNWYNKRIALIER

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server